Contact: Perry Sacks psacks@skdknick.com 202-464-6611 FOR IMMEDIATE RELEASE August 8, 2016 Funds Will Allow Ebola Patients Expanded Access to Experimental Treatment August 8, 2016 – SAN DIEGO – Today, Mapp Biopharmaceutical, Inc. (Mapp Bio) announced it has received funding from Biomedical Advanced Research and Development Authority (BARDA), part of
Mapp Bio Receives HHS Funding for Expanded Access Protocol for Ebola Treatment
